Journal of Transportation Security, Journal Year: 2024, Volume and Issue: 17(1)
Published: Dec. 1, 2024
Language: Английский
Journal of Transportation Security, Journal Year: 2024, Volume and Issue: 17(1)
Published: Dec. 1, 2024
Language: Английский
MedComm, Journal Year: 2024, Volume and Issue: 5(11)
Published: Oct. 20, 2024
Abstract Cancer is a leading cause of morbidity and mortality worldwide, an increase in incidence estimated the next future, due to population aging, which requires development highly tolerable low‐toxicity cancer treatment strategies. The use nanotechnology tailor treatments according genetic immunophenotypic characteristics patient's tumor, allow its targeted release, can meet this need, improving efficacy minimizing side effects. Nanomedicine‐based approach for diagnosis rapidly evolving field. Several nanoformulations are currently clinical trials, some have been approved marketed. However, their large‐scale production still hindered by in‐depth debate involving ethics, intellectual property, safety health concerns, technical issues, costs. Here, we survey key approaches, with specific reference organ‐on chip technology, cutting‐edge tools, such as CRISPR/Cas9 genome editing, through nanosystems needs personalized diagnostics therapy patients. An update provided on nanopharmaceuticals marketed those undergoing trials. Finally, discuss emerging avenues field challenges be overcome transfer nano‐based precision oncology into daily life.
Language: Английский
Citations
2Journal of Transportation Security, Journal Year: 2024, Volume and Issue: 17(1)
Published: Dec. 1, 2024
Language: Английский
Citations
0